{"count": 5, "results": [{"_id": "10694831", "pmid": 10694831, "title": "Induction of insulin resistance by beta-blockade but not ACE-inhibition: long-term treatment with atenolol or trandolapril.", "journal": "J Hum Hypertens", "authors": ["Reneland R", "Alvarez E", "Andersson PE", "Haenni A", "Byberg L", "Lithell H"], "date": "2000-03-01T00:00:00Z", "doi": "10.1038/sj.jhh.1000964", "meta_date_publication": "2000 Mar", "meta_volume": "14", "meta_issue": "3", "meta_pages": "175-80", "score": 50061.688, "text_hl": "Induction of @<m>DISEASE_Insulin_Resistance</m> @DISEASE_MESH:D007333 @@@insulin resistance@@@ by beta-blockade but not @GENE_ACE @GENE_1636 @@@ACE@@@-inhibition: long-term treatment with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ or @CHEMICAL_trandolapril @CHEMICAL_MESH:C052035 @@@trandolapril@@@.", "citations": {"NLM": "Reneland R, Alvarez E, Andersson PE, Haenni A, Byberg L, Lithell H. Induction of insulin resistance by beta-blockade but not ACE-inhibition: long-term treatment with atenolol or trandolapril. J Hum Hypertens. 2000 Mar;14(3):175-80. PMID: 10694831", "BibTeX": "@article{10694831, title={Induction of insulin resistance by beta-blockade but not ACE-inhibition: long-term treatment with atenolol or trandolapril.}, author={Reneland R and Alvarez E and Andersson PE and Haenni A and Byberg L and Lithell H}, journal={J Hum Hypertens}, volume={14}, number={3}, pages={175-80}}"}}, {"_id": "21247745", "pmid": 21247745, "title": "The beta-1 adrenergic antagonist, atenolol, decreases acylation stimulating protein, exercise capacity and plasma free fatty acids in men with type 2 diabetes.", "journal": "Nutr Metab Cardiovasc Dis", "authors": ["Smith J", "Ferland A", "Méthot J", "Brassard P", "Lacroix S", "Poirier P", "Cianflone K"], "date": "2012-06-01T00:00:00Z", "doi": "10.1016/j.numecd.2010.08.008", "meta_date_publication": "2012 Jun", "meta_volume": "22", "meta_issue": "6", "meta_pages": "495-502", "score": 50047.355, "text_hl": "...BACKGROUND AND AIMS: @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ is a beta-1 adrenergic antagonist commonly prescribed for the treatment of systemic @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ or @DISEASE_Coronary_Artery_Disease @DISEASE_MESH:D003324 @@@coronary artery disease@@@ yet its use in individuals with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ (@DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@) is controversial due to potentially negative side effects on @<m>DISEASE_Insulin_Resistance</m> @DISEASE_MESH:D007333 @@@insulin resistance@@@. ", "citations": {"NLM": "Smith J, Ferland A, Méthot J, Brassard P, Lacroix S, Poirier P, Cianflone K. The beta-1 adrenergic antagonist, atenolol, decreases acylation stimulating protein, exercise capacity and plasma free fatty acids in men with type 2 diabetes. Nutr Metab Cardiovasc Dis. 2012 Jun;22(6):495-502. PMID: 21247745", "BibTeX": "@article{21247745, title={The beta-1 adrenergic antagonist, atenolol, decreases acylation stimulating protein, exercise capacity and plasma free fatty acids in men with type 2 diabetes.}, author={Smith J and Ferland A and Méthot J and Brassard P and Lacroix S and Poirier P and Cianflone K}, journal={Nutr Metab Cardiovasc Dis}, volume={22}, number={6}, pages={495-502}}"}}, {"_id": "9672774", "pmid": 9672774, "title": "Differential effects of selective beta-adrenergic blockade on insulin sensitivity and release in control subjects and in patients with angina and normal coronary arteries (syndrome X).", "journal": "G Ital Cardiol", "authors": ["Fragasso G", "Cattaneo N", "Locatelli M", "Caumo A", "Pagnotta P", "Piatti P", "Bonini P", "Chierchia SL"], "date": "1998-06-01T00:00:00Z", "meta_date_publication": "1998 Jun", "meta_volume": "28", "meta_issue": "6", "meta_pages": "623-9", "score": 50047.105, "text_hl": "The aim of the study was to evaluate the effects of short-term treatment with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ on @CHEMICAL_Carbohydrates @CHEMICAL_MESH:D002241 @@@carbohydrate@@@ metabolism in @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@syndrome X@@@ @SPECIES_9606 @@@patients@@@, as compared to normal subjects. ", "citations": {"NLM": "Fragasso G, Cattaneo N, Locatelli M, Caumo A, Pagnotta P, Piatti P, Bonini P, Chierchia SL. Differential effects of selective beta-adrenergic blockade on insulin sensitivity and release in control subjects and in patients with angina and normal coronary arteries (syndrome X). G Ital Cardiol. 1998 Jun;28(6):623-9. PMID: 9672774", "BibTeX": "@article{9672774, title={Differential effects of selective beta-adrenergic blockade on insulin sensitivity and release in control subjects and in patients with angina and normal coronary arteries (syndrome X).}, author={Fragasso G and Cattaneo N and Locatelli M and Caumo A and Pagnotta P and Piatti P and Bonini P and Chierchia SL}, journal={G Ital Cardiol}, volume={28}, number={6}, pages={623-9}}"}}, {"_id": "9416986", "pmid": 9416986, "title": "Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes.", "journal": "J Hum Hypertens", "authors": ["Fogari R", "Zoppi A", "Lazzari P", "Mugellini A", "Lusardi P", "Preti P", "Van Nueten L", "Vertommen C"], "date": "1997-11-01T00:00:00Z", "doi": "10.1038/sj.jhh.1000533", "meta_date_publication": "1997 Nov", "meta_volume": "11", "meta_issue": "11", "meta_pages": "753-7", "score": 50044.613, "text_hl": "These findings indicate that, in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@NIDDM@@@, ie, in subjects who have established @<m>DISEASE_Insulin_Resistance</m> @DISEASE_MESH:D007333 @@@insulin resistance@@@, treatment with @CHEMICAL_Nebivolol @CHEMICAL_MESH:D000068577 @@@nebivolol@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ neither further deteriorated @GENE_INS @GENE_3630 @@@insulin@@@ sensitivity nor adversely affected the @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ profile.", "citations": {"NLM": "Fogari R, Zoppi A, Lazzari P, Mugellini A, Lusardi P, Preti P, Van Nueten L, Vertommen C. Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes. J Hum Hypertens. 1997 Nov;11(11):753-7. PMID: 9416986", "BibTeX": "@article{9416986, title={Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes.}, author={Fogari R and Zoppi A and Lazzari P and Mugellini A and Lusardi P and Preti P and Van Nueten L and Vertommen C}, journal={J Hum Hypertens}, volume={11}, number={11}, pages={753-7}}"}}, {"_id": "8762212", "pmid": 8762212, "title": "Metabolic neutrality of combined verapamil-trandolapril treatment in contrast to beta-blocker-low-dose chlortalidone treatment in hypertensive type 2 diabetes.", "journal": "J Hypertens", "authors": ["Schneider M", "Lerch M", "Papiri M", "Buechel P", "Boehlen L", "Shaw S", "Risen W", "Weidmann P"], "date": "1996-05-01T00:00:00Z", "doi": "10.1097/00004872-199605000-00018", "meta_date_publication": "1996 May", "meta_volume": "14", "meta_issue": "5", "meta_pages": "669-77", "score": 50033.53, "text_hl": "However, although the @CHEMICAL_Verapamil @CHEMICAL_MESH:D014700 @@@verapamil@@@-@CHEMICAL_trandolapril @CHEMICAL_MESH:C052035 @@@trandolapril@@@ combination was found to be metabolically neutral, the @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@-@CHEMICAL_Chlorthalidone @CHEMICAL_MESH:D002752 @@@chlortalidone@@@ combination aggravated @<m>DISEASE_Insulin_Resistance</m> @DISEASE_MESH:D007333 @@@insulin resistance@@@ [@GENE_INS @GENE_3630 @@@insulin@@@ sensitivity index, from (0.8 +/- 0.2) to (0.3 +/- 0.1) x 10(-4)/min per U per ml], increased the serum @CHEMICAL_Triglycerides @CHEMICAL_MESH:D014280 @@@triglycerides@@@ level and decreased the high-density lipoprotein cholesterol and plasma @CHEMICAL_Potassium @CHEMICAL_MESH:D011188 @@@potassium@@@ levels. ", "citations": {"NLM": "Schneider M, Lerch M, Papiri M, Buechel P, Boehlen L, Shaw S, Risen W, Weidmann P. Metabolic neutrality of combined verapamil-trandolapril treatment in contrast to beta-blocker-low-dose chlortalidone treatment in hypertensive type 2 diabetes. J Hypertens. 1996 May;14(5):669-77. PMID: 8762212", "BibTeX": "@article{8762212, title={Metabolic neutrality of combined verapamil-trandolapril treatment in contrast to beta-blocker-low-dose chlortalidone treatment in hypertensive type 2 diabetes.}, author={Schneider M and Lerch M and Papiri M and Buechel P and Boehlen L and Shaw S and Risen W and Weidmann P}, journal={J Hypertens}, volume={14}, number={5}, pages={669-77}}"}}]}